Patents Examined by Jeffery E Russel
  • Glycogen synthase kinase-3 inhibitors
    Patent number: 7446092
    Abstract: Novel conjugates that are capable of inhibiting GSK-3 activity, a process of producing same, pharmaceutical compositions including same and methods of using same in the treatment of GSK-3 mediated conditions are disclosed. Methods of treating affective disorders using GSK-3 inhibitors are further disclosed.
    Type: Grant
    Filed: December 11, 2003
    Date of Patent: November 4, 2008
    Assignee: Tel Aviv University Future Technology Development L.P.
    Inventor: Hagit Eldar-Finkelman